Tetsuyoshi Kawakami

534 total citations
5 papers, 399 citations indexed

About

Tetsuyoshi Kawakami is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Tetsuyoshi Kawakami has authored 5 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Nephrology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Tetsuyoshi Kawakami's work include Parathyroid Disorders and Treatments (3 papers), CAR-T cell therapy research (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Tetsuyoshi Kawakami is often cited by papers focused on Parathyroid Disorders and Treatments (3 papers), CAR-T cell therapy research (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Tetsuyoshi Kawakami collaborates with scholars based in Japan, Singapore and United Kingdom. Tetsuyoshi Kawakami's co-authors include Xiaoping Zhang, Karl Insogna, Erik A. Imel, Takahiro Ito, Thomas O. Carpenter, Mark A. Klausner, Mary D. Ruppe, Jeffrey S. Humphrey, Thomas J. Weber and Munro Peacock and has published in prestigious journals such as Journal of Clinical Investigation, Clinical Cancer Research and Annals of Oncology.

In The Last Decade

Tetsuyoshi Kawakami

5 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tetsuyoshi Kawakami Japan 4 201 198 102 72 65 5 399
Daphne H.T. IJpelaar Netherlands 8 37 0.2× 246 1.2× 106 1.0× 39 0.5× 117 1.8× 17 466
Hajime Shimada Japan 9 103 0.5× 111 0.6× 36 0.4× 15 0.2× 124 1.9× 22 347
Gopala K. Rangan Australia 10 31 0.2× 285 1.4× 141 1.4× 34 0.5× 95 1.5× 13 481
Haruhiko Hirai Japan 8 39 0.2× 78 0.4× 17 0.2× 98 1.4× 155 2.4× 16 337
Songlin Piao China 10 85 0.4× 118 0.6× 21 0.2× 60 0.8× 219 3.4× 15 398
Jun Zou China 13 20 0.1× 138 0.7× 42 0.4× 34 0.5× 143 2.2× 27 400
Clinton C. Bertram United States 10 23 0.1× 90 0.5× 119 1.2× 24 0.3× 109 1.7× 14 365
Bjoern Mayer Germany 7 34 0.2× 41 0.2× 58 0.6× 79 1.1× 64 1.0× 8 382

Countries citing papers authored by Tetsuyoshi Kawakami

Since Specialization
Citations

This map shows the geographic impact of Tetsuyoshi Kawakami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuyoshi Kawakami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuyoshi Kawakami more than expected).

Fields of papers citing papers by Tetsuyoshi Kawakami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuyoshi Kawakami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuyoshi Kawakami. The network helps show where Tetsuyoshi Kawakami may publish in the future.

Co-authorship network of co-authors of Tetsuyoshi Kawakami

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuyoshi Kawakami. A scholar is included among the top collaborators of Tetsuyoshi Kawakami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuyoshi Kawakami. Tetsuyoshi Kawakami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Doi, Toshihiko, Kei Muro, Hiroshi Ishii, et al.. (2019). A Phase I Study of the Anti-CC Chemokine Receptor 4 Antibody, Mogamulizumab, in Combination with Nivolumab in Patients with Advanced or Metastatic Solid Tumors. Clinical Cancer Research. 25(22). 6614–6622. 124 indexed citations
2.
Yamamoto, Noboru, Kei Muro, Hiroshi Ishii, et al.. (2017). Anti-CC-chemokine receptor 4 (CCR4) antibody mogamulizumab (Moga) and nivolumab (Nivo) combination phase I study in patients with advanced or metastatic solid tumors. Annals of Oncology. 28. v611–v611. 8 indexed citations
3.
Carpenter, Thomas O., Erik A. Imel, Mary D. Ruppe, et al.. (2014). Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia. Journal of Clinical Investigation. 124(4). 1587–1597. 215 indexed citations
4.
5.
Nakashima, Daisuke, Yuko Ogasawara, Tetsuyoshi Kawakami, et al.. (2007). Effect of Cinacalcet Hydrochloride, a New Calcimimetic Agent, on the Pharmacokinetics of Dextromethorphan: In Vitro and Clinical Studies. The Journal of Clinical Pharmacology. 47(10). 1311–1319. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daphne H.T. IJpelaar Breakdown of academic impact, for papers by Hajime Shimada Breakdown of academic impact, for papers by Gopala K. Rangan Breakdown of academic impact, for papers by Haruhiko Hirai Breakdown of academic impact, for papers by Songlin Piao Breakdown of academic impact, for papers by Jun Zou Breakdown of academic impact, for papers by Clinton C. Bertram Breakdown of academic impact, for papers by Bjoern Mayer
Rankless by CCL
2026